Axem Accepted into Prestigious 2019 TMCx Digital Health Accelerator

Axem Neurotechnology Inc. is thrilled to announce our acceptance into the 2019 TMCx Digital Health Accelerator Cohort. This honor places us among a select group of companies that have demonstrated exceptional innovation in the digital health sector.

The TMCx team, consisting of experts from across the Texas Medical Center and beyond, reviewed an impressive array of digital health solutions from around the globe. Axem's inclusion in this competitive cohort is a testament to our innovative approach and the potential of our neurotechnology solutions. The program, beginning on February 11, 2019, includes a three-week bootcamp followed by a series of intensive curriculum sessions and networking events. It culminates on June 6, 2019, with the TMCx Demo Day, where we will have the opportunity to present our work to a broad audience of investors, clinical experts, and industry leaders.

We are excited to embark on this journey with TMCx and look forward to leveraging the opportunities and insights this program will offer.